References
Key articles
Kiriyama S, Kozaka K, Takada T, et al. Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholangitis (with videos). J Hepatobiliary Pancreat Sci. 2018 Jan;25(1):17-30.Full text Abstract
Miura F, Okamoto K, Takada T, et al. Tokyo Guidelines 2018: initial management of acute biliary infection and flowchart for acute cholangitis. J Hepatobiliary Pancreat Sci. 2018 Jan;25(1):31-40.Full text Abstract
Gomi H, Solomkin JS, Schlossberg D, et al. Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci. 2018 Jan;25(1):3-16.Full text Abstract
Mayumi T, Okamoto K, Takada T, et al. Tokyo Guidelines 2018: management bundles for acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci. 2018 Jan;25(1):96-100.Full text Abstract
Mukai S, Itoi T, Baron TH, et al. Indications and techniques of biliary drainage for acute cholangitis in updated Tokyo Guidelines 2018. J Hepatobiliary Pancreat Sci. 2017 Oct;24(10):537-49.Full text Abstract
Reference articles
1. Kiriyama S, Kozaka K, Takada T, et al. Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholangitis (with videos). J Hepatobiliary Pancreat Sci. 2018 Jan;25(1):17-30.Full text Abstract
3. Rumsey S, Winders J, MacCormick AD. Diagnostic accuracy of Charcot's triad: a systematic review. ANZ J Surg. 2017 Apr;87(4):232-8.Full text Abstract
4. Das AK. Hepatic and biliary ascariasis. J Glob Infect Dis. 2014 Apr;6(2):65-72.Full text Abstract
5. Alam S, Mustafa G, Ahmad N, et al. Presentation and endoscopic management of biliary ascariasis. Southeast Asian J Trop Med Public Health. 2007 Jul;38(4):631-5. Abstract
6. Verweij KE, van Buuren H. Oriental cholangiohepatitis (recurrent pyogenic cholangitis): a case series from the Netherlands and brief review of the literature. Neth J Med. 2016 Nov;74(9):401-5.Full text Abstract
7. Carmona RH, Crass RA, Lim RC Jr, et al. Oriental cholangitis. Am J Surg. 1984 Jul;148(1):117-24. Abstract
8. What if it's acute cholangitis? Drug Ther Bull. 2005 Aug;43(8):62-4. Abstract
9. Ahmed M. Acute cholangitis - an update. World J Gastrointest Pathophysiol. 2018 Feb 15;9(1):1-7.Full text Abstract
10. Kimura Y, Takada T, Strasberg SM, et al. TG13 current terminology, etiology, and epidemiology of acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci. 2013 Jan;20(1):8-23.Full text Abstract
11. Higuchi R, Takada T, Strasberg SM, et al; Tokyo Guideline Revision Committee. TG13 miscellaneous etiology of cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci. 2013 Jan;20(1):97-105.Full text Abstract
12. American College of Gastroenterology. Diagnosis and management of biliary strictures. Mar 2023 [internet publication].Full text
13. Qureshi WA. Approach to the patient who has suspected acute bacterial cholangitis. Gastroenterol Clin North Am. 2006 Jun;35(2):409-23. Abstract
14. Pitt HA, Couse NF. Biliary sepsis and toxic cholangitis. In: Moody FG, Carey LC, eds. Surgical treatment of digestive diseases. 2nd ed. Chicago: Year Book Medical Publishers; 1990:332.
15. Hanau LH, Steigbigel NH. Acute (ascending) cholangitis. Infect Dis Clin North Am. 2000 Sep;14(3):521-46. Abstract
16. Lavillegrand JR, Mercier-Des-Rochettes E, Baron E, et al. Acute cholangitis in intensive care units: clinical, biological, microbiological spectrum and risk factors for mortality: a multicenter study. Crit Care. 2021 Feb 6;25(1):49.Full text Abstract
17. Naseer M, Dailey FE, Juboori AA, et al. Epidemiology, determinants, and management of AIDS cholangiopathy: a review. World J Gastroenterol. 2018 Feb 21;24(7):767-74.Full text Abstract
18. Radulescu L, Crisan D, Grapa C, et al. Digestive toxicities secondary to immune checkpoint inhibition therapy - reports of rare events. a systematic review. J Gastrointestin Liver Dis. 2021 Dec 21;30(4):506-16.Full text Abstract
19. Pi B, Wang J, Tong Y, et al. Immune-related cholangitis induced by immune checkpoint inhibitors: a systematic review of clinical features and management. Eur J Gastroenterol Hepatol. 2021 Dec 1;33(1s suppl 1):e858-67.Full text Abstract
20. Löhr JM, Beuers U, Vujasinovic M, et al. European guideline on IgG4-related digestive disease - UEG and SGF evidence-based recommendations. United European Gastroenterol J. 2020 Jul;8(6):637-66.Full text Abstract
21. Dumonceau JM, Kapral C, Aabakken L, et al. ERCP-related adverse events: European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy. 2020 Feb;52(2):127-49.Full text Abstract
22. Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016 Feb 23;315(8):801-10.Full text Abstract
23. American College of Emergency Physicians (ACEP) Expert Panel on Sepsis. DART: an evidence-driven tool to guide the early recognition and treatment of sepsis and septic shock. 2016 [internet publication].Full text
24. Churpek MM, Snyder A, Han X, et al. Quick sepsis-related organ failure assessment, systemic inflammatory response syndrome, and early warning scores for detecting clinical deterioration in infected patients outside the intensive care unit. Am J Respir Crit Care Med. 2017 Apr 1;195(7):906-11.Full text Abstract
25. Smith GB, Prytherch DR, Meredith P, et al. The ability of the National Early Warning Score (NEWS) to discriminate patients at risk of early cardiac arrest, unanticipated intensive care unit admission, and death. Resuscitation. 2013 Apr;84(4):465-70. Abstract
26. Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021 Nov;47(11):1181-247.Full text Abstract
27. Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Crit Care Med. 2021 Nov 1;49(11):e1063-143.Full text Abstract
28. Nutbeam T, Daniels R on behalf of the UK Sepsis Trust. Sepsis: clinical tools. 2022 [internet publication].Full text
29. Daniels R, Nutbeam T, McNamara G, et al. The sepsis six and the severe sepsis resuscitation bundle: a prospective observational cohort study. Emerg Med J. 2011 Jun;28(6):507-12.Full text Abstract
30. Miura F, Okamoto K, Takada T, et al. Tokyo Guidelines 2018: initial management of acute biliary infection and flowchart for acute cholangitis. J Hepatobiliary Pancreat Sci. 2018 Jan;25(1):31-40.Full text Abstract
31. Gomi H, Solomkin JS, Schlossberg D, et al. Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci. 2018 Jan;25(1):3-16.Full text Abstract
32. Simundic AM, Bölenius K, Cadamuro J, et al. Joint EFLM-COLABIOCLI recommendation for venous blood sampling. Clin Chem Lab Med. 2018;56(12):2015-38. Abstract
33. Manes G, Paspatis G, Aabakken L, et al. Endoscopic management of common bile duct stones: European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy. 2019 May;51(5):472-91.Full text Abstract
34. Bonomo RA, Edwards MS, Abrahamian FM, et al. 2024 Clinical practice guideline update by the Infectious Diseases Society of America on Complicated Intraabdominal Infections: diagnostic imaging of suspected acute cholecystitis and acute cholangitis in adults, children, and pregnant people. Clin Infect Dis. 2024 Oct 4;79(suppl 3):S104-8.Full text Abstract
35. Buxbaum JL, Buitrago C, Lee A, et al. ASGE guideline on the management of cholangitis. Gastrointest Endosc. 2021 Aug;94(2):207-21.e14. Abstract
36. Verma D, Kapadia A, Eisen GM, et al. EUS vs MRCP for detection of choledocholithiasis. Gastrointest Endosc. 2006 Aug;64(2):248-54. Abstract
37. Mohan R, Goh SWL, Tan G, et al. Validation of TG07 and TG13/TG18 criteria for acute cholangitis and predictors of in-hospital mortality in patients over 80 years old. Clin Exp Hepatol. 2021 Dec;7(4):396-405.Full text Abstract
38. Isayama H, Nakai Y, Itoi T, et al. Clinical practice guidelines for safe performance of endoscopic ultrasound/ultrasonography-guided biliary drainage: 2018. J Hepatobiliary Pancreat Sci. 2019 Jul;26(7):249-69.Full text Abstract
39. Mayumi T, Okamoto K, Takada T, et al. Tokyo Guidelines 2018: management bundles for acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci. 2018 Jan;25(1):96-100.Full text Abstract
40. European Medicines Agency. Disabling and potentially permanent side effects lead to suspension or restrictions of quinolone and fluoroquinolone antibiotics. 11 March 2019 [internet publication].Full text
41. Food and Drug Administration. Drug Safety Communication: FDA warns about increased risk of ruptures or tears in the aorta blood vessel with fluoroquinolone antibiotics in certain patients. 20 December 2018 [internet publication].Full text
42. Food and Drug Administration. FDA reinforces safety information about serious low blood sugar levels and mental health side effects with fluoroquinolone antibiotics; requires label changes. 10 July 2018 [internet publication].Full text
43. Mukai S, Itoi T, Baron TH, et al. Indications and techniques of biliary drainage for acute cholangitis in updated Tokyo Guidelines 2018. J Hepatobiliary Pancreat Sci. 2017 Oct;24(10):537-49.Full text Abstract
44. Yasuda I, Itoi T. Recent advances in endoscopic management of difficult bile duct stones. Dig Endosc. 2013 Jul;25(4):376-85.Full text Abstract
45. Du L, Cen M, Zheng X, et al. Timing of performing endoscopic retrograde cholangiopancreatography and inpatient mortality in acute cholangitis: a systematic review and meta-analysis. Clin Transl Gastroenterol. 2020 Mar;11(3):e00158.Full text Abstract
46. Iqbal U, Khara HS, Hu Y, et al. Emergent versus urgent ERCP in acute cholangitis: a systematic review and meta-analysis. Gastrointest Endosc. 2020 Apr;91(4):753-60.e4. Abstract
47. Mok SR, Mannino CL, Malin J, et al. Does the urgency of endoscopic retrograde cholangiopancreatography (ercp)/percutaneous biliary drainage (pbd) impact mortality and disease related complications in ascending cholangitis? (deim-i study). J Interv Gastroenterol. 2012 Oct;2(4):161-7.Full text Abstract
48. Mulki R, Shah R, Qayed E. Early vs late endoscopic retrograde cholangiopancreatography in patients with acute cholangitis: a nationwide analysis. World J Gastrointest Endosc. 2019 Jan 16;11(1):41-53.Full text Abstract
49. Parbhu SK, Siddiqui AA, Taylor LJ, et al. Initial report of outpatient management of acute cholangitis via ERCP. Dig Dis Sci. 2017 Jun;62(6):1676-7. Abstract
50. Alkhatib AA, Hilden K, Adler DG. Comorbidities, sphincterotomy, and balloon dilation predict post-ERCP adverse events in PSC patients: operator experience is protective. Dig Dis Sci. 2011 Dec;56(12):3685-8. Abstract
51. Webster J, Osborne S, Rickard CM, et al. Clinically-indicated replacement versus routine replacement of peripheral venous catheters. Cochrane Database Syst Rev. 2019 Jan 23;(1):CD007798.Full text Abstract
52. Hu B, Wang TT, Wu J, et al. Antireflux stents to reduce the risk of cholangitis in patients with malignant biliary strictures: a randomized trial. Endoscopy. 2014 Feb;46(2):120-6. Abstract
53. Lee KJ, Chung MJ, Park JY, et al. Clinical advantages of a metal stent with an S-shaped anti-reflux valve in malignant biliary obstruction. Dig Endosc. 2013 May;25(3):308-12. Abstract
54. Lin H, Li S, Liu X. The safety and efficacy of nasobiliary drainage versus biliary stenting in malignant biliary obstruction: a systematic review and meta-analysis. Medicine (Baltimore). 2016 Nov;95(46):e5253.Full text Abstract
55. Hamada T, Nakai Y, Isayama H, et al. Antireflux metal stent for biliary obstruction: any benefits? Dig Endosc. 2021 Mar;33(3):310-20.Full text Abstract
56. American College of Radiology. ACR appropriateness criteria®: radiologic management of biliary obstruction. 2018 [internet publication].Full text
Use of this content is subject to our disclaimer